Blokland, A. S., Koornstra, R. H., Tolmeijer, S. H., Westgeest, H. M., Boers-Sonderen, M. J., Kapiteijn, E., Blank, C. U., Eertwegh, A. J. M. V. D., Suijkerbuijk, K., Rijn, R. V., Aarts, M. J., Berkmortel, F. V. D., Vreugdenhil, G., Jalving, M., Ligtenberg, M. J., Mehra, N., Groot, J. W. D., Bol, K. (2026). Combination of vemurafenib with cobimetinib in
                    <i>BRAF</i>
                    V600E/K mutated melanoma patients to normalize LDH and optimize immunotherapy with nivolumab and ipilimumab (COWBOY): A randomized, open-label phase 2 clinical trial.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.9513